SBIR/STTR Research Award
A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION
Award amount
$2,180,197Program and phase
SBIR · Phase IIAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ZATA PHARMACEUTICALS, INC.
- Proposal award date
- 2020-03-15
- Contract end date
- 2022-02-28
- UEI
- LM1CSJF7LLS6
- Solicitation number
- PA18-574
- Topic code
- NHLBI
Research abstract
TBD
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Highly Selective Pathogen Inactivators For Treatment of Convalescent Transfusion Plasma
- A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION
- New-Generation of Fluorescently-Labeled Charge-Neutralized Oligonucleotides as Probes for the Detection and Quantification of MicroRNAs and Oligonucleotide-Based Therapeutics in Biological Samples
- SELF NEUTRALIZING OLIGONUCLEOTIDES WITH ENHANCED CELLULAR UPTAKE
- AZIRIDINYL GROUPS CONTAINING POLYAMINES AS ANTI-PATHOGEN DEVICE FOR BLOOD PRODUCTS INTENDED FOR TRANSFUSION